Skip to main content

More data from PAISLEY, deucravacitinib in SLE Small but significant benefit w/respect to joints, a little disappointin

Social Author Name
Mike Putman
Tweet Content
More data from PAISLEY, deucravacitinib in SLE Small but significant benefit w/respect to joints, a little disappointing tbh Would like to see this for all manifestations ie pericarditis, pleuritis, etc Anyone have an infographic or useful chart? #ACR20 @RheumNow Abstr#1552 https://t.co/tXUoUtssxo
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×